Logo
E

Evosep Biosystems

80 employees

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.

Investor insights

Funding rounds participated in

$40M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2016

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

E

Evosep Biosystems raised $40M on February 9, 2023

Investors: Novo Holdings

FAQ